RAB6C expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.897190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.611000E-01
Normal-vs-Stage2
2.093000E-01
Normal-vs-Stage3
9.189900E-02
Normal-vs-Stage4
5.250400E-01
Stage1-vs-Stage2
7.165200E-01
Stage1-vs-Stage3
2.022200E-01
Stage1-vs-Stage4
9.611400E-01
Stage2-vs-Stage3
3.809400E-01
Stage2-vs-Stage4
7.241000E-01
Stage3-vs-Stage4
3.314800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.353040E-01
Normal-vs-AfricanAmerican
2.398400E-01
Normal-vs-Asian
9.991400E-01
Caucasian-vs-AfricanAmerican
1.390030E-01
Caucasian-vs-Asian
1.534030E-01
AfricanAmerican-vs-Asian
7.470400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.349700E-02
Normal-vs-Female
3.551200E-01
Male-vs-Female
1.031990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.117570E-01
Normal-vs-Age(41-60Yrs)
3.490800E-01
Normal-vs-Age(61-80Yrs)
1.476850E-01
Normal-vs-Age(81-100Yrs)
2.858800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.588180E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.202800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.574600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.958000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.035600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.058200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.122300E-02
Normal-vs-Daily Drinker
1.454200E-01
Normal-vs-Weekly Drinker
8.295900E-03
Normal-vs-Occasional Drinker
2.466000E-01
Normal-vs-Social Drinker
9.624300E-02
Non Drinker-vs-Daily Drinker
8.601800E-01
Non Drinker-vs-Weekly Drinker
1.607010E-01
Non Drinker-vs-Occasional Drinker
1.965580E-01
Non Drinker-vs-Social Drinker
8.646800E-01
Daily Drinker-vs-Weekly Drinker
1.799450E-01
Daily Drinker-vs-Occasional Drinker
3.403000E-01
Daily Drinker-vs-Social Drinker
7.739000E-01
Weekly Drinker-vs-Occasional Drinker
1.387940E-02
Weekly Drinker-vs-Social Drinker
2.766000E-01
Occasional Drinker-vs-Social Drinker
2.177800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.564040E-01
Normal-vs-Grade 2
4.736100E-02
Normal-vs-Grade 3
8.687900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.139800E-01
Grade 1-vs-Grade 3
9.029800E-01
Grade 1-vs-Grade 4
1.564040E-01
Grade 2-vs-Grade 3
5.360800E-01
Grade 2-vs-Grade 4
4.736100E-02
Grade 3-vs-Grade 4
8.687900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.050300E-02
Normal-vs-NonDiabetic
2.281600E-01
Diabetic-vs-NonDiabetic
4.156500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.998100E-02
Normal-vs-NoPancreatitis
1.284410E-01
Pancreatitis-vs-NoPancreatitis
4.075800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.171970E-01
Normal-vs-N1
2.052600E-01
N0-vs-N1
8.998600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.626000E-01
Normal-vs-TP53-NonMutant
1.164630E-01
TP53-Mutant-vs-TP53-NonMutant
8.259700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
